Taking Advantage of a Sharply Changing Environment Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Taking Advantage of a Sharply Changing Environment

NRG 155.17

+3.8%

11:21 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Doug R who wrote (3679)	5/11/2020 1:20:52 PM
From: Hawkmoon	1 Recommendation Recommended By Doug R Read Replies (2) of 6356

Not impressed by that study, or Campbell's analysis. Their MUST be randomized, blind, studies, and especially for those who are diagnosed early, and by adding Zinc to the protocol. Looking for peer-review on this paper.. "In univariate analyses, zinc sulfate increased the frequency of patients being discharged home, and decreased the need for ventilation, admission to the ICU, and mortality or transfer to hospice for patients who were never admitted to the ICU. After adjusting for the time at which zinc sulfate was added to our protocol, an increased frequency of being discharged home (OR 1.53, 95% CI 1.12-2.09) reduction in mortality or transfer to hospice remained significant (OR 0.449, 95% CI 0.271-0.744). Conclusion: This study provides the first in vivo evidence that zinc sulfate in combination with hydroxychloroquine may play a role in therapeutic management for COVID-19." medrxiv.org Gotta give it early on.. not when the body's immune system has been compromised by excessive viral loading. This thing doesn't just attack ACE2 receptors, but Immune T cells. Hawk

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next